{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:47:31Z","timestamp":1791402451248,"version":"4.3.3"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Krychman ML and Katz A. Breast cancer and sexuality: Multi-modal treatment options. J Sex Med **;**:**\u2013**<\/jats:title>\n                  <jats:p>The sexual consequences of breast cancer and its treatments are well known and previously reviewed. Alterations in body image, with or without breast reconstruction, changes in sexual self-esteem and self-efficacy, vulvovaginal atrophy as a result of chemotherapy and\/or adjuvant hormone therapy, and loss of libido secondary to dyspareunia and body image issues are common in survivors of breast cancer. Medications that are prescribed for long-term use including those in the class of aromatase inhibitors can have far-reaching implications on quality of life by contributing to vulvar and vaginal atrophic changes. While this is an important issue, there are few widely accepted treatments that have been evaluated for efficacy and safety for these sexual challenges in the breast cancer population. However, progress is being made in finding new and innovative solutions for many of the sexual problems faced by breast cancer survivors and their partners. Many institutions are now compelled to address survivorship concerns and addressing sexuality and intimacy are paramount issues in survivorship care. In this article, we present the evidence for the multimodal approach to the management of sexuality concerns in the breast cancer survivor. Pharmacologic, nonpharmacologic, and psychosocial interventions will be reviewed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02566.x","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T18:19:45Z","timestamp":1323281985000},"page":"5-13","source":"Crossref","is-referenced-by-count":68,"title":["Breast Cancer and Sexuality: Multi-modal Treatment Options (CME)"],"prefix":"10.1093","volume":"9","author":[{"given":"Michael L.","family":"Krychman","sequence":"first","affiliation":[{"name":"Southern California Center for Sexual Health and Survivorship Medicine and Clinical Faculty USC , Newport Beach, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Katz","sequence":"additional","affiliation":[{"name":"Cancer Care Manitoba and Faculty of Nursing, University of Manitoba , Winnipeg , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2024032600391277900_bb0010","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone replacement therapy after breast cancer: A meta-analysis and critical appraisal of the evidence","volume":"7","author":"Col","year":"2005","journal-title":"Breast Cancer Res"},{"key":"2024032600391277900_bb0015","first-page":"1017","article-title":"Clinical practice guideline for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer","volume":"166","author":"Pritchard","year":"2002","journal-title":"CMAJ"},{"key":"2024032600391277900_bb0020","first-page":"216","article-title":"Use of hormonal replacement therapy after treatment of breast cancer. Number 142, May 2004","volume":"88","author":"Society of Obstetricians and Gynaecologists of Canada","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"2024032600391277900_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/gme.0b013e318051718c","article-title":"The role of local estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement on the North American Menopause Society","volume":"14","author":"North American Menopause Society","year":"2007","journal-title":"Menopause"},{"key":"2024032600391277900_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1524-4741.2011.01089.x","article-title":"Current overview of the management of urogenital atrophy in women with breast cancer","volume":"17","author":"Pruthi","year":"2011","journal-title":"Breast J"},{"key":"2024032600391277900_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"key":"2024032600391277900_bb0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjunct aromatase inhibitors","volume":"17","author":"Kendal","year":"2006","journal-title":"Ann Oncol"},{"key":"2024032600391277900_bb0045","author":"Memorial Sloan-Kettering Cancer Center Clinical Trial","year":"2010","journal-title":"Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen"},{"key":"2024032600391277900_bb0050","first-page":"448","article-title":"Ospemifene hormos","volume":"5","author":"Gennari","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"2024032600391277900_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.GME.0000063609.62485.27","article-title":"Effects of ospemifene, a novel SERM, on hormones genital tract, climacteric symptoms and quality of life in postmenopausal women: A double-blind randomized trial","volume":"10","author":"Rutanen","year":"2004","journal-title":"Menopause"},{"key":"2024032600391277900_bb0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"key":"2024032600391277900_bb0065","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/gme.0b013e31819e8e2d","article-title":"Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"issue":"1","key":"2024032600391277900_bb0070","first-page":"S276","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: A phase I\/II study","volume":"106","author":"Witherby","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2024032600391277900_bb0075","author":"Vaginal testosterone cream for atrophic vaginitis in women taking aromatase inhibitors for breast cancer","journal-title":"NCT01122342"},{"key":"2024032600391277900_bb0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djk149","article-title":"Randomized clinical trial to evaluate transdermal testosterone in female cancer survivors with decreased libido. North Central Cancer Treatment Group Protocol N02C3","volume":"99","author":"Barton","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2024032600391277900_bb0085","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1743-6109.2007.00577.x","article-title":"A case series of androgen use in breast cancer survivors with sexual dysfunction","volume":"4","author":"Krychman","year":"2007","journal-title":"J Sex Med"},{"issue":"1","key":"2024032600391277900_bb0090","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3747\/co.2007.151","article-title":"Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy","volume":"14","author":"Derko","year":"2007","journal-title":"Curr Oncol"},{"key":"2024032600391277900_bb0095","article-title":"Libigel Clinical Trial Update","author":"Snabes","year":"2010","journal-title":"Poster Presentation at the North American Menopause Society Chicago"},{"key":"2024032600391277900_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4088\/JCP.v65n0110","article-title":"A placebo controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor induced sexual dysfunction","volume":"65","author":"Clayton","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2024032600391277900_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinthera.2007.02.006","article-title":"Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review","volume":"29","author":"Bordeleau","year":"2007","journal-title":"Clin Ther"},{"key":"2024032600391277900_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-006-9428-0","article-title":"The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen","volume":"101","author":"Goetz","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"2024032600391277900_bb0115","author":"Rae","year":"2010","journal-title":"Lack of correlation between gene variants in tamoxifen metabolizing enzymes with primary endpoints in the ATAC trial [abstract S1-7]. Abstract presented at: 33rd Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 8\u201312, 2010"},{"key":"2024032600391277900_bb0120","article-title":"BIG 1-98 Collaborative Group and International Breast Cancer Study Group, Bern, Switzerland","author":"Leyland-Jones","journal-title":"2010 Outcome according to CYP 2D6 genotype among postmenopausal women with endocrine-responsive early invasive breast cancer randomized in the BIG 1-98 Trial [abstract S1\u20138]. Abstract presented at: 33rd Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 8\u201312, 2010"},{"key":"2024032600391277900_bb0125","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1001\/jama.2008.693","article-title":"Sildenafil as treatment for antidepressant-induced sexual dysfunction","volume":"300","author":"Hong","year":"2008","journal-title":"JAMA"},{"key":"2024032600391277900_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1743-6109.2007.00698.x","article-title":"Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: A double-blind placebo-controlled, fixed dose, randomized study","volume":"5","author":"Safarinejad","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600391277900_bb0135","first-page":"85S","article-title":"Sexual dysfunction","volume":"104","author":"American College of Obstetricians and Gynecologists Task Force on Hormone Therapy","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2024032600391277900_bb0140","first-page":"222","article-title":"SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004","volume":"88","author":"Society of Obstetricians and Gynaecologists of Canada","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"2024032600391277900_bb0145","first-page":"1","article-title":"Treating dyspareunia caused by vaginal atrophy: A review of treatment options using vaginal estrogen therapy","volume":"2","author":"Kingsberg","year":"2009","journal-title":"Int J Women\u2019s Health"},{"key":"2024032600391277900_bb0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1743-6109.2010.01988.x","article-title":"Simple strategies for vaginal health promotion in cancer survivors","volume":"8","author":"Carter","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600391277900_bb0155","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","article-title":"Vaginal pH balanced gel for the control of atrophic vaginitis among breast cancer survivors","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2024032600391277900_bb0160","first-page":"S1","article-title":"A positive approach to female sexual health: A summary report","volume":"34","author":"Hutcherson","year":"2009","journal-title":"Female Patient"},{"key":"2024032600391277900_bb0165","first-page":"722","article-title":"Meta-analysis of estrogen therapy in the management of uro-genital atrophy in postmenopausal women: Second report of the Hormones and Urogenital Therapy Committee","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"key":"2024032600391277900_bb0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/713846828","article-title":"Double blind placebo controlled study of arginimax, a nutritional supplement for enhancement of female sexual function","volume":"27","author":"Ito","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"2024032600391277900_bb0175","first-page":"20","article-title":"Sexuality and breast cancer. Coping magazine","author":"Krychman","year":"2009"},{"key":"2024032600391277900_bb0180","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1524-4741.2009.00766.x","article-title":"Quality of life after breast cancer: Survivorship and sexuality","volume":"15","author":"Dizon","year":"2009","journal-title":"Breast J"},{"key":"2024032600391277900_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PPO.0b013e31819585df","article-title":"A review of couple-based interventions for enhancing women\u2019s sexual adjustment and body image after cancer","volume":"15","author":"Scott","year":"2009","journal-title":"Cancer J"},{"key":"2024032600391277900_bb0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/00926238308410913","article-title":"Postmastectomy couple counseling: An outcome study of a structured treatment protocol","volume":"9","author":"Christensen","year":"1983","journal-title":"J Sex Marital Ther"},{"key":"2024032600391277900_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/pon.1395","article-title":"A couple-based intervention for female breast cancer","volume":"18","author":"Baucom","year":"2009","journal-title":"Psychooncology"},{"key":"2024032600391277900_bb0200","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1037\/0022-006X.72.6.1122","article-title":"United we stand? The effects of a couple-coping intervention on adjustment to early stage breast or gynecological cancer","volume":"72","author":"Scott","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"2024032600391277900_bb0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jso.20811","article-title":"Combined brief psychosexual intervention after mastectomy: Effects on sexuality, body image, and psychological well-being","volume":"96","author":"Kalaitzi","year":"2007","journal-title":"J Surg Oncol"},{"key":"2024032600391277900_bb0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-009-0398-x","article-title":"Addressing intimacy and partner communication after breast cancer: A randomized controlled group intervention","volume":"118","author":"Rowland","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2024032600391277900_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/NCC.0b013e3181f1ab7a","article-title":"The effect of a Sexual Life Reframing program on marital intimacy, body image, and sexual function among breast cancer survivors","volume":"34","author":"Jun","year":"2011","journal-title":"Cancer Nurs"},{"key":"2024032600391277900_bb0220","author":"Duijts","journal-title":"Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: Design of a multi-center study, BMC Women\u2019s Health2009"},{"key":"2024032600391277900_bb0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.NCC.0000339252.91194.6c","article-title":"Young female breast cancer survivors. Their sexual function and interest in sexual enhancement products and services","volume":"31","author":"Herbenick","year":"2008","journal-title":"Cancer Nurs"},{"key":"2024032600391277900_bb0230","article-title":"Mindfulness based stress reduction in post-treatment breast cancer patients: An examination of symptoms and symptom clusters","author":"Lengacher","year":"2011","journal-title":"J Behav Med"},{"key":"2024032600391277900_bb0235","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/pon.1529","article-title":"Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer","volume":"18","author":"Lengacher","year":"2009","journal-title":"Psychooncology"},{"key":"2024032600391277900_bb0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0898010110385938","article-title":"Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors","volume":"29","author":"Lengacher","year":"2011","journal-title":"J Holist Nurs"},{"key":"2024032600391277900_bb0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/NCC.0b013e3181e2d0df","article-title":"Experiences of a mindfulness-based stress-reduction intervention among patients with cancer","volume":"34","author":"Kvillemo","year":"2011","journal-title":"Cancer Nurs"},{"key":"2024032600391277900_bb0250","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1037\/a0017566","article-title":"Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: A randomized controlled trial","volume":"78","author":"Foley","year":"2010","journal-title":"J Consult Clin Psychol"},{"key":"2024032600391277900_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1091-7527.22.2.193","article-title":"Mindfulness-based stress reduction in women with breast cancer","volume":"22","author":"Tacon","year":"2004","journal-title":"Fam Syst Health"},{"key":"2024032600391277900_bb0260","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1743-6109.2008.00850.x","article-title":"A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women","volume":"5","author":"Brotto","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600391277900_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14681990601153298","article-title":"Mindfulness in sex therapy: Applications for women with sexual difficulties following gynecological cancer","volume":"22","author":"Brotto","year":"2007","journal-title":"Sex Relat Therapy"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951533722X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951533722X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/5\/47770825\/jsm_9_1_5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/5\/47770825\/jsm_9_1_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:33:23Z","timestamp":1711416803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/1\/5\/6886961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02566.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,1]]},"published":{"date-parts":[[2012,1,1]]}}}